Physician profile
Justin P Schultz
NPI 1770933772
$5,696.31
in general payments reported to CMS, 2019-2025
44 companies · $1,207 in 2025
The $1,207 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $521 · 2020: $45.80 · 2021: $474 · 2022: $1,147 · 2023: $1,248 · 2024: $1,053 · 2025: $1,207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,496 · Education: $13.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,495.50 |
| Education | $13.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $654.01 | 2021-2025 | Botox, Lupron Depot |
| Coloplast Corp | $601.63 | 2021-2025 | Speedicath, Titan, Altis |
| Boston Scientific Corporation | $576.64 | 2019-2025 | Tria Firm, Lithovue, Lumenis Pulse 120h |
| Pfizer INC. | $509.01 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $384.40 | 2023-2025 | Orgovyx, Gemtesa |
| Myriad Genetic Laboratories, INC. | $324.95 | 2021-2024 | Prolaris |
| Astellas Pharma US INC | $287.46 | 2021-2023 | Myrbetriq |
| Procept Biorobotics Corporation | $210.93 | 2019-2025 | |
| 180 Medical, INC. | $194.79 | 2021-2024 | Gentlecath, Gentlecath Glide |
| Janssen Biotech, INC. | $148.09 | 2021-2025 | Erleada |
| Urogen Pharma, INC. | $139.31 | 2022-2025 | Jelmyto |
| Axonics, INC. | $125.31 | 2021-2024 | Axonics |
| Tolmar, INC. | $114.30 | 2023-2025 | Eligard, Jatenzo |
| Ambu INC. | $103.99 | 2024 | |
| Abbott Laboratories | $88.80 | 2025 | I-Stat |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $79.02 | 2021-2022 | |
| Hollister Incorporated | $77.69 | 2021-2023 | Vapro, Vapro Pocket |
| Angiodynamics, INC. | $77.52 | 2023-2025 | Nanoknife |
| Ferring Pharmaceuticals INC. | $71.18 | 2024-2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $70.88 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $62.36 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $62.05 | 2023-2025 | Bard Urinary Drainage Bag |
| Myovant Sciences INC. | $59.20 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $53.78 | 2022-2024 | |
| Baxter Healthcare | $52.49 | 2025 | Tisseel, Perclot |
| Smith+Nephew, INC. | $48.02 | 2022 | |
| Teleflex LLC | $47.14 | 2021-2023 | Urolift |
| Endo USA, INC. | $44.92 | 2024-2025 | Xiaflex, Aveed |
| Olympus America INC. | $42.02 | 2025 | Itind System |
| Cook Medical LLC | $36.31 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $34.91 | 2021 | |
| Dendreon Pharmaceuticals LLC | $34.81 | 2023 | Provenge |
| Laborie Medical Technologies Corp. | $34.68 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Astrazeneca Pharmaceuticals LP | $34.61 | 2023-2025 | Lynparza |
| Amgen INC. | $30.82 | 2022-2023 | Evenity, Prolia |
| Calyxo, INC. | $29.57 | 2025 | Cvac Aspiration System |
| Inspire Medical Systems, INC. | $23.64 | 2025 | Inspire |
| Merck Sharp & Dohme LLC | $22.95 | 2022 | |
| Urovant Sciences INC | $21.25 | 2022 | |
| Medtronic, INC. | $19.94 | 2023 | Interstim |
| Verity Pharmaceuticals INC. | $19.16 | 2023 | Trelstar |
| Clarus Therapeutics INC. | $15.78 | 2021 | |
| Photocure INC | $14.26 | 2022 | |
| Accord Healthcare, INC. | $11.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.